Hwang SY - Search Results

1

Promoter analysis of the Drosophila genes encoding TFIIB and TATA box-binding protein.

Cho N, Oh Y, Hwang SY, Han D, Park SP, Yoon J, Han K, Baek K. Cho N, et al. Among authors: hwang sy. Mol Cells. 1998 Dec 31;8(6):770-6. Mol Cells. 1998. PMID: 9895133 Free article.

2

Structural modification of an orally active thrombin inhibitor, LB30057: replacement of the D-pocket-binding naphthyl moiety.

Lee K, Hwang SY, Hong S, Hong CY, Lee CS, Shin Y, Kim S, Yun M, Yoo YJ, Kang M, Oh YS. Lee K, et al. Among authors: hwang sy. Bioorg Med Chem. 1998 Jun;6(6):869-76. doi: 10.1016/s0968-0896(98)00044-3. Bioorg Med Chem. 1998. PMID: 9681152

3

Discovery of LB30057, a benzamidrazone-based selective oral thrombin inhibitor.

Oh YS, Yun M, Hwang SY, Hong S, Shin Y, Lee K, Yoon KH, Yoo YJ, Kim DS, Lee SH, Lee YH, Park HD, Lee CH, Lee SK, Kim S. Oh YS, et al. Among authors: hwang sy. Bioorg Med Chem Lett. 1998 Mar 17;8(6):631-4. doi: 10.1016/s0960-894x(98)00079-1. Bioorg Med Chem Lett. 1998. PMID: 9871573

4

Augmentation of therapeutic antitumor immunity by B16F10 melanoma cells transfected by interferon-gamma and allogeneic MHC class I cDNAs.

Lim YS, Kang BY, Kim EJ, Kim SH, Hwang SY, Kim TS. Lim YS, et al. Among authors: hwang sy. Mol Cells. 1998 Oct 31;8(5):629-36. Mol Cells. 1998. PMID: 9856353 Free article.

5

Inhibition of interleukin-12 production in lipopolysaccharide-activated macrophages by curcumin.

Kang BY, Chung SW, Chung W, Im S, Hwang SY, Kim TS. Kang BY, et al. Among authors: hwang sy. Eur J Pharmacol. 1999 Nov 19;384(2-3):191-5. doi: 10.1016/s0014-2999(99)00690-1. Eur J Pharmacol. 1999. PMID: 10611441

6

Thrombin inhibitors based on a propargylglycine template.

Lee K, Hwang SY, Park CW. Lee K, et al. Among authors: hwang sy. Bioorg Med Chem Lett. 1999 Apr 5;9(7):1013-8. doi: 10.1016/s0960-894x(99)00125-0. Bioorg Med Chem Lett. 1999. PMID: 10230630

7

Fluorobenzamidrazone thrombin inhibitors: influence of fluorine on enhancing oral absorption.

Lee K, Jung WH, Hwang SY, Lee SH. Lee K, et al. Among authors: hwang sy. Bioorg Med Chem Lett. 1999 Sep 6;9(17):2483-6. doi: 10.1016/s0960-894x(99)00412-6. Bioorg Med Chem Lett. 1999. PMID: 10498193

8

Antigen-specific cytotoxicity and cell number of adoptively transferred T cells are efficiently maintained in vivo by re-stimulation with an antigen/interleukin-2 fusion protein.

Kang BY, Lim YS, Chung SW, Kim EJ, Kim SH, Hwang SY, Kim TS. Kang BY, et al. Among authors: hwang sy. Int J Cancer. 1999 Aug 12;82(4):569-73. doi: 10.1002/(sici)1097-0215(19990812)82:4<569::aid-ijc16>3.0.co;2-m. Int J Cancer. 1999. PMID: 10404072

9

Potent and efficacious thienylamidine-incorporated thrombin inhibitors.

Lee K, Hwang SY, Yun M, Kim DS. Lee K, et al. Among authors: hwang sy. Bioorg Med Chem Lett. 1998 Jul 7;8(13):1683-6. doi: 10.1016/s0960-894x(98)00293-5. Bioorg Med Chem Lett. 1998. PMID: 9873414

10

Interleukin-2 fusion protein with anti-CD3 single-chain Fv (sFv) selectively protects T cells from dexamethasone-induced apoptosis.

Kim EJ, Cho D, Hwang SY, Kim TS. Kim EJ, et al. Among authors: hwang sy. Vaccine. 2001 Nov 12;20(3-4):608-15. doi: 10.1016/s0264-410x(01)00331-0. Vaccine. 2001. PMID: 11672928

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,155 results

Search Page

Filters